These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Healthcare workers and the incidence of nosocomial infection: can treatment of one influence the other?--a brief review. Wenzel RP J Chemother; 1994 Sep; 6 Suppl 4():33-7; discussion 39-40. PubMed ID: 7861212 [TBL] [Abstract][Full Text] [Related]
10. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections]. García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556 [TBL] [Abstract][Full Text] [Related]
11. Elimination of Staphylococcus aureus in hemodialysis patients. Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815 [TBL] [Abstract][Full Text] [Related]
12. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. Fawley WN; Parnell P; Hall J; Wilcox MH J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029 [TBL] [Abstract][Full Text] [Related]
13. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309 [TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. Boelaert JR J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051 [TBL] [Abstract][Full Text] [Related]
15. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240 [TBL] [Abstract][Full Text] [Related]
17. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Lederer SR; Riedelsdorf G; Schiffl H Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699 [TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389 [TBL] [Abstract][Full Text] [Related]